| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Apr―18 |
SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs |
Sho Iketani, David D. Ho |
| 2 |
[GO] |
2023―Aug―15 |
Multimodal, broadly neutralizing antibodies against SARS-CoV-2 identified by high-throughput native pairing of BCRs from bulk B cells |
Gladys J. Keitany, Benjamin E.R. Rubin, Meghan E. Garrett, Andrea Musa, Jeff Tracy, Yu Liang, et al. (+29) Peter Ebert, Amanda J. Moore, Jonathan Guan, Erica Eggers, Ninnia Lescano, Ryan Brown, Adria Carbo, Hussein Al-Asadi, Travers Ching, Austin Day, Rebecca Harris, Charles Linkem, Dimitry Popov, Courtney Wilkins, Lianqu Li, Jiao Wang, Chuanxin Liu, Li Chen, Jennifer N. Dines, Caroline Atyeo, Galit Alter, Lance Baldo, Anna Sherwood, Bryan Howie, Mark Klinger, Erik Yusko, Harlan S. Robins, Sharon Benzeno, Amy E. Gilbert |
| 3 |
[GO] |
2023―Jul―26 |
High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface |
Suprama Datta, Da-Yuan Chen, Alexander H. Tavares, Tamara Reyes-Robles, Keun Ah Ryu, Nazimuddin Khan, et al. (+10) Tyler J. Bechtel, Jayde M. Bertoch, Cory H. White, Daria J. Hazuda, Kalpit A. Vora, Erik C. Hett, Olugbeminiyi O. Fadeyi, Rob C. Oslund, Andrew Emili, Mohsan Saeed |
| 4 |
[GO] |
2023―Jun―25 |
Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization |
Scott A. McConnell, Jaiprasath Sachithanandham, Nathan J. Mudrak, Xianming Zhu, Parsa Alba Farhang, Radames J.B. Cordero, et al. (+9) Maggie P. Wear, Janna R. Shapiro, Han-Sol Park, Sabra L. Klein, Aaron A.R. Tobian, Evan M. Bloch, David J. Sullivan, Andrew Pekosz, Arturo Casadevall |
| 5 |
[GO] |
2023―Mrz―16 |
Getting in on the action: New tools to see SARS-CoV-2 infect a cell |
Scott B. Hansen, Zixuan Yuan |
| 6 |
[GO] |
2023―Mrz―07 |
Therapeutic potency of compound RMY-205 for pulmonary fibrosis induced by SARS-CoV-2 nucleocapsid protein |
Zhi-yuan Zhang, Cui-yu Ju, Liu-zheng Wu, Han Yan, Wen-bin Hong, Hang-zi Chen, et al. (+9) Peng-bo Yang, Bao-Rui Wang, Tong Gou, Xiao-yan Chen, Zhi-hong Jiang, Wei-jia Wang, Tianwei Lin, Fu-nan Li, Qiao Wu |
| 7 |
[GO] |
2023―Mrz―07 |
SIM imaging resolves endocytosis of SARS-CoV-2 spike RBD in living cells |
Lu Miao, Chunyu Yan, Yingzhu Chen, Wei Zhou, Xuelian Zhou, Qinglong Qiao, Zhaochao Xu |
| 8 |
[GO] |
2022―Feb―02 |
Generation of an anticoagulant aptamer that targets factor V/Va and disrupts the FVa-membrane interaction in normal and COVID-19 patient samples |
Erin E. Soule, Haixiang Yu, Lyra Olson, Ibtehaj Naqvi, Shekhar Kumar, Sriram Krishnaswamy, Bruce A. Sullenger |
| 9 |
[GO] |
2022―Jan―11 |
Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses |
Valeria Napolitano, Agnieszka Dabrowska, Kenji Schorpp, André Mourão, Emilia Barreto-Duran, Malgorzata Benedyk, et al. (+24) Pawel Botwina, Stefanie Brandner, Mark Bostock, Yuliya Chykunova, Anna Czarna, Grzegorz Dubin, Tony Fröhlich, Michael Hölscher, Malwina Jedrysik, Alex Matsuda, Katarzyna Owczarek, Magdalena Pachota, Oliver Plettenburg, Jan Potempa, Ina Rothenaigner, Florian Schlauderer, Klaudia Slysz, Artur Szczepanski, Kristin Greve-Isdahl Mohn, Bjorn Blomberg, Michael Sattler, Kamyar Hadian, Grzegorz Maria Popowicz, Krzysztof Pyrc |
| 10 |
[GO] |
2021―Okt―22 |
An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity |
Yuehui Zhang, Limin Shang, Jing Zhang, Yuchen Liu, Chaozhi Jin, Yanan Zhao, et al. (+13) Xiaobo Lei, Wenjing Wang, Xia Xiao, Xiuyuan Zhang, Yujiao Liu, Linlin Liu, Meng-Wei Zhuang, Qingkun Mi, Chunyan Tian, Jianwei Wang, Fuchu He, Pei-Hui Wang, Jian Wang |
| 11 |
[GO] |
2021―Jul―02 |
SARS-COV-2 Spike binding to ACE2 in living cells monitored by TR-FRET |
Erika Cecon, Matilda Burridge, Longxing Cao, Lauren Carter, Rashmi Ravichandran, Julie Dam, Ralf Jockers |
| 12 |
[GO] |
2021―Jun―25 |
An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor |
Daniel Zaidman, Paul Gehrtz, Mihajlo Filep, Daren Fearon, Ronen Gabizon, Alice Douangamath, et al. (+11) Jaime Prilusky, Shirly Duberstein, Galit Cohen, C. David Owen, Efrat Resnick, Claire Strain-Damerell, Petra Lukacik, Haim Barr, Martin A. Walsh, Frank von Delft, Nir London |
| 13 |
[GO] |
2021―Jun―24 |
Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis |
Jennifer M. Zupancic, Alec A. Desai, John S. Schardt, Ghasidit Pornnoppadol, Emily K. Makowski, Matthew D. Smith, et al. (+6) Andrew A. Kennedy, Mayara Garcia de Mattos Barbosa, Marilia Cascalho, Thomas M. Lanigan, Andrew W. Tai, Peter M. Tessier |
| 14 |
[GO] |
2021―Apr―27 |
Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2 |
Hengyue Shan, Jianping Liu, Jiali Shen, Jialin Dai, Gang Xu, Kuankuan Lu, et al. (+12) Chao Han, Yaru Wang, Xiaolong Xu, Yilun Tong, Huaijiang Xiang, Zhiyuan Ai, Guanglei Zhuang, Junhao Hu, Zheng Zhang, Ying Li, Lifeng Pan, Li Tan |
|
